Fundamentals - IDEXX Laboratories (IDXX)

Segments are charted by their disclosed metrics (revenue, segment profit, etc.). Each line is a single segment. Reconciliation/corporate items are excluded. Major customers are shown as a percentage of revenue. Operational KPIs are grouped by metric concept; sub-metrics appear as separate lines.

Geographic Segments

No 10-Q data

Business Unit / Product Segments

No 10-Q data

Major Customers (% of Revenue)

Operational KPIs

Recurring diagnostic revenue share (arr)

No 10-Q data

Reagent rental future revenue (backlog)

Hematology analyzer installed base (capacity)

No 10-Q data

Software installed base (customers)

No 10-Q data

Employee Engagement (engagement)

No 10-Q data

Technical service personnel (headcount)

Distributor inventory (inventory_units)

No 10-K data

Open purchase orders (order_book)

No 10-K data

Accounts receivable over 60 days past due (other)

No 10-K data

Accounts receivable past due (other)

No 10-K data

Acquired business contribution to segment growth (other)

No 10-K data

Acquisition contribution to revenue growth (other)

No 10-K data

Acquisitions completed (other)

No 10-K data

Active installed base growth (other)

No 10-K data

Adjusted EBITDA (other)

No 10-K data

Aggregate intrinsic value of options (other)

No 10-K data

Allowance for credit losses (other)

No 10-K data

Allowance for credit losses - accounts receivable (other)

No 10-K data

Allowance for credit losses - contract assets (other)

No 10-K data

Amortization expense (other)

No 10-K data

Average cost per treasury share (other)

No 10-K data

Average open market repurchase price (other)

No 10-K data

Average repurchase price (other)

No 10-K data

Blue Ridge products in registration (other)

No 10-Q data

Borrowing availability (other)

No 10-K data

Borrowings outstanding (other)

No 10-K data

CAG revenue mix (other)

No 10-Q data

Capital budget (other)

No 10-K data

Capital expenditure guidance (other)

No 10-K data

Capital expenditure plan (other)

No 10-K data

Capital expenditures (other)

No 10-K data

Capital expenditures guidance (other)

No 10-K data

Capital expenditures paid (other)

No 10-K data

Capital purchase commitment (other)

No 10-K data

Capitalized consideration paid to customers (other)

No 10-K data

Capitalized customer acquisition costs (other)

No 10-K data

Cardiopet cases handled (other)

No 10-Q data

Cases handled per year (other)

No 10-Q data

Cash and cash equivalents (other)

No 10-K data

Cash and investments (other)

No 10-K data

Cash and marketable securities (other)

No 10-K data

Cash and short-term investments (other)

No 10-K data

Cash, cash equivalents and marketable securities (other)

No 10-K data

Catalyst Analyzer Installed Base (other)

No 10-Q data

Catalyst Chemistry Analyzers Installed Base (other)

No 10-Q data

Catalyst analyzers installed base (other)

No 10-Q data

Catalyst and VetTest chemistry analyzers installed base (other)

No 10-Q data

Catalyst placements (other)

No 10-Q data

Catalyst placements to new accounts (other)

No 10-Q data

Chemistry analyzer installed base (other)

No 10-Q data

Chemistry analyzers installed base (other)

No 10-Q data

Chemistry slide inventory (other)

No 10-K data

Chemistry slide inventory turns (other)

No 10-K data

Chemistry slide remaining shelf life (other)

No 10-K data

Clinical visits growth (other)

No 10-Q data

Closing price per share (other)

No 10-K data

Closing stock price (other)

No 10-K data

Common Stock Shares Outstanding (other)

No 10-Q data

Common shares outstanding (other)

Consulting cases handled (other)

No 10-Q data

Consumable revenue share (other)

No 10-Q data

Contingent consideration liability (other)

No 10-K data

Contract assets (other)

No 10-K data

Contract assets - volume commitment programs (other)

No 10-K data

Cost of shares repurchased (other)

No 10-K data

Countries of operation (other)

Countries served (other)

Countries with operations (other)

No 10-Q data

Countries with product sales (other)

No 10-Q data

Countries with sales (other)

No 10-Q data

Countries with sales offices (other)

No 10-Q data

Credit facility availability (other)

No 10-K data

Credit facility borrowing availability (other)

No 10-K data

Cumulative share repurchase cost (other)

No 10-K data

Cumulative shares repurchased (other)

No 10-K data

Cumulative shares repurchased under buyback program (other)

No 10-K data

Cumulative treasury shares repurchased (other)

No 10-K data

Currency impact on revenue (other)

No 10-K data

Days sales outstanding (other)

Debt to Adjusted EBITDA ratio (other)

No 10-K data

Deferred commission costs (other)

No 10-K data

Deferred revenue balance (other)

No 10-K data

Dehydrated culture media products (other)

No 10-Q data

Depreciation and amortization (other)

No 10-K data

Depreciation expense (other)

No 10-K data

Diluted earnings per share (other)

No 10-K data

Diluted weighted average shares (other)

No 10-K data

Distributor inventory (other)

No 10-K data

Distributor inventory coverage (other)

Distributor inventory impact on revenue growth (other)

No 10-K data

Distributor inventory level (other)

No 10-K data

Distributor inventory value (other)

No 10-Q data

Distributor inventory weeks (other)

No 10-K data

Distributor inventory weeks of supply (other)

No 10-K data

Distributor weeks of inventory (other)

No 10-K data

EPM market share target (other)

No 10-K data

EPM market size (other)

No 10-K data

EPM treatment market (other)

No 10-K data

EPM treatments market (other)

No 10-K data

Effective income tax rate (other)

No 10-K data

Effective tax rate (other)

No 10-K data

Employee engagement level (other)

No 10-Q data

Employees departed (other)

No 10-K data

Employees terminated (other)

No 10-K data

European revenue growth (other)

No 10-K data

Expected option term (other)

No 10-K data

Expected stock price volatility (other)

No 10-K data

Export revenue share (other)

No 10-K data

FX hedge notional amount (other)

No 10-K data

FX impact on revenue (other)

No 10-K data

Fair value of awards granted (other)

No 10-K data

Fair value of options granted (other)

No 10-K data

Fair value of options vested (other)

No 10-K data

Fair value per restricted/deferred stock unit (other)

No 10-K data

Foreign Patent Applications (other)

No 10-Q data

Foreign Patents (other)

No 10-Q data

Foreign countries with operations (other)

No 10-K data

Foreign countries with subsidiaries (other)

Foreign country operations (other)

Foreign country subsidiaries (other)

Foreign currency hedge notional (other)

No 10-K data

Foreign currency impact on revenue (other)

No 10-K data

Foreign exchange hedge losses (other)

No 10-K data

Foreign operations footprint (other)

No 10-K data

Foreign patents held (other)

No 10-Q data

Foreign subsidiaries (other)

No 10-K data

General and administrative expense (other)

No 10-K data

General and administrative expense ratio (other)

No 10-K data

Goodwill (other)

No 10-K data

Goodwill impairment headroom (other)

No 10-K data

Gross debt (other)

No 10-K data

Gross debt to Adjusted EBITDA (other)

No 10-K data

Gross debt to Adjusted EBITDA ratio (other)

No 10-K data

Gross debt to adjusted EBITDA (other)

No 10-K data

Gross margin (other)

No 10-K data

Gross margin percentage (other)

No 10-K data

Gross profit margin (other)

No 10-K data

Hedge notional amount (other)

No 10-K data

Hematology Analyzer Installed Base (other)

No 10-Q data

Hematology Analyzers Installed Base (other)

No 10-Q data

Hematology analyzer installed base (other)

No 10-Q data

Hematology analyzers installed base (other)

No 10-Q data

Holders of record (other)

No 10-Q data

Incremental acquisition sales guidance (other)

No 10-K data

Independent distributors (other)

No 10-Q data

Installed base growth (other)

No 10-Q data

Installed base instruments (other)

No 10-Q data

Installed base units (other)

No 10-Q data

Instrument installed base (other)

No 10-Q data

Interest rate swap notional (other)

No 10-K data

International revenue (other)

No 10-Q data

International revenue growth (other)

No 10-K data

International revenue share (other)

International sales mix (other)

No 10-K data

International sales offices (other)

No 10-Q data

International share of sales (other)

No 10-Q data

Inventory turns (other)

LPD international sales share (other)

No 10-Q data

Land owned (other)

No 10-Q data

LaserCyte component inventory (other)

No 10-K data

LaserCyte inventory (other)

No 10-K data

LaserCyte purchase commitments (other)

No 10-K data

Lease receivable assets (other)

No 10-K data

Litigation accrual (other)

No 10-K data

Minimum purchase obligation (other)

No 10-K data

Minimum slide purchase commitment (other)

No 10-K data

NAVIGATOR inventory (other)

No 10-K data

Net cash provided by operating activities (other)

No 10-K data

Net debt (other)

No 10-K data

Net debt to Adjusted EBITDA (other)

No 10-K data

Net debt to Adjusted EBITDA ratio (other)

No 10-K data

Net debt to adjusted EBITDA (other)

No 10-K data

Net intangible assets and goodwill (other)

No 10-K data

New platform production assets (other)

No 10-K data

Nitazoxanide inventory (other)

No 10-K data

Nitazoxanide raw material inventory (other)

No 10-K data

Non-compliance testing revenue share (other)

No 10-K data

Non-compliance testing share (other)

No 10-K data

Number of Reportable Segments (other)

Operating cash flow (other)

No 10-K data

Operating lease liabilities (other)

No 10-K data

Operating lease maturities (other)

No 10-K data

Operating margin (other)

No 10-K data

Operating profit impact from currency (other)

No 10-K data

Options exercised (other)

No 10-K data

Options forfeited (other)

No 10-K data

Options granted (other)

No 10-K data

Options outstanding (other)

No 10-K data

Organic revenue growth (other)

Outstanding borrowings under Credit Facility (other)

No 10-K data

Outstanding stock options (other)

No 10-K data

PAS international sales share (other)

No 10-Q data

Patent applications filed (other)

No 10-Q data

Patents held (other)

No 10-Q data

Pharmaceutical product revenue share (other)

No 10-K data

Planned capital expenditures (other)

No 10-K data

Practice revenue growth (other)

No 10-Q data

Premium Catalyst chemistry analyzers installed base (other)

No 10-Q data

Premium hematology analyzers installed base (other)

No 10-Q data

Premium instrument installed base (other)

No 10-Q data

Premium instrument installed base growth (other)

No 10-K data

ProCyte placements (other)

No 10-Q data

ProCyte placements to competitive accounts (other)

No 10-Q data

Products offered (other)

No 10-Q data

Purchase rights issued (other)

No 10-K data

R&D Projects (other)

No 10-Q data

Recurring diagnostic revenue mix (other)

No 10-Q data

Recurring diagnostic revenue share (other)

No 10-Q data

Recurring revenue share (other)

No 10-Q data

Remaining borrowing availability (other)

No 10-K data

Remaining buyback authorization (other)

No 10-K data

Remaining expense recognition period (other)

No 10-K data

Remaining repurchase authorization (other)

No 10-K data

Remaining share repurchase authorization (other)

No 10-K data

Rent expense (other)

No 10-K data

Reported revenue growth (other)

No 10-K data

Repurchase authorization remaining (other)

No 10-K data

Research and development expense (other)

Research and development expense ratio (other)

No 10-K data

Research and development expense share (other)

No 10-Q data

Research and development spend (other)

No 10-Q data

Restricted stock units outstanding (other)

No 10-K data

Revenue from U.S.-manufactured products sold internationally (other)

No 10-K data

Revenue from customers outside U.S. (other)

No 10-K data

Revenue from international sales (other)

No 10-K data

Revenue from outside U.S. (other)

No 10-K data

Revenue growth (other)

No 10-K data

Revenue impact from currency (other)

No 10-K data

Revenue impact of 1% stronger U.S. dollar (other)

No 10-K data

Revenue manufactured in U.S. and sold internationally (other)

No 10-K data

Revenue manufactured in U.S. sold internationally (other)

No 10-K data

Revolver borrowings outstanding (other)

No 10-K data

Risk-free interest rate (other)

No 10-K data

Sales and marketing expense (other)

No 10-K data

Sales and marketing expense ratio (other)

No 10-K data

Sales and marketing spend (other)

No 10-Q data

Sales offices outside US (other)

No 10-Q data

SediVue Dx analyzers installed base (other)

No 10-Q data

SediVue Dx installed base (other)

No 10-Q data

Segment revenue mix (other)

No 10-K data

Share-based compensation expense (other)

No 10-K data

Shares Outstanding (other)

No 10-Q data

Shares outstanding (other)

Shares received for option exercises (other)

No 10-K data

Shares remaining under repurchase authorization (other)

No 10-K data

Shares repurchased (other)

Slide purchase commitment (other)

No 10-K data

Stock options outstanding (other)

No 10-K data

Stockholders of record (other)

No 10-Q data

Total revenue growth (other)

No 10-K data

Treasury shares held (other)

No 10-K data

Treasury shares outstanding (other)

No 10-K data

Treasury shares purchased (other)

No 10-K data

Treasury shares repurchased (other)

No 10-K data

Treasury stock shares (other)

No 10-K data

U.S. Patent Applications (other)

No 10-Q data

U.S. Patents (other)

No 10-Q data

U.S. Veterinary Hospitals (other)

No 10-Q data

U.S. patents held (other)

No 10-Q data

U.S.-manufactured export revenue share (other)

No 10-K data

US Patent Applications (other)

No 10-Q data

US Patents (other)

No 10-Q data

US patents held (other)

No 10-Q data

Underrepresented minorities (other)

No 10-Q data

Unrecognized compensation cost (other)

No 10-K data

Unrecognized share-based compensation (other)

No 10-K data

Unrecognized share-based compensation cost (other)

No 10-K data

VetTest analyzer installed base (other)

No 10-Q data

VetTest analyzers installed base (other)

No 10-Q data

VetTest slide inventory turns (other)

VetTest slide purchase commitment (other)

No 10-K data

VetTest slides inventory (other)

No 10-K data

VetTest slides inventory turns (other)

No 10-K data

VetTest slides remaining shelf life (other)

No 10-K data

Veterinary hospitals in North America (other)

No 10-Q data

Veterinary practice software installations (other)

No 10-Q data

Volume commitment contract assets (other)

No 10-K data

Voluntary Turnover Rate (other)

No 10-Q data

Voluntary employee turnover (other)

No 10-Q data

Voluntary employee turnover rate (other)

No 10-Q data

Voluntary managerial turnover (other)

No 10-Q data

Voluntary turnover rate (other)

No 10-Q data

Warranty provision (other)

No 10-K data

Warranty reserve (other)

No 10-K data

Warranty reserve balance (other)

No 10-K data

Water international sales share (other)

No 10-Q data

Weighted average basic shares (other)

No 10-K data

Weighted average diluted shares (other)

No 10-K data

Weighted average discount rate - operating leases (other)

No 10-K data

Weighted average effective interest rate (other)

No 10-K data

Weighted average interest rate (other)

No 10-K data

Weighted average lease term (other)

No 10-K data

Weighted average remaining lease term (other)

No 10-K data

Women in Global Senior Executive (other)

No 10-Q data

Women in Global Senior Leadership (other)

No 10-Q data

Women in global employees (other)

No 10-Q data

Working capital (other)

No 10-K data

Cardiopet cases handled (procedures)

No 10-Q data

US veterinary laboratory facilities (properties)

No 10-Q data

Committed future revenue (rpo)

Diagnostics revenue per practice growth (same_store_sales)

No 10-Q data

Land owned (square_footage)

No 10-Q data

Human capital disclosures. Workforce totals and demographics are point-in-time. Flow metrics use the year-to-date period for 10-Q and full year for 10-K. Workforce actions (RIFs, restructurings, acquisition-related changes) are listed in the table at the bottom.

Workforce Totals

No 10-Q data

Demographics

No 10-Q data

Workforce Breakdowns

No 10-Q data

HCM Metrics — Point-in-Time

No 10-Q data

HCM Metrics — Flow (Annual / YTD)

No 10-Q data

Workforce Actions

Period End	Type	Status	Affected	Announced	Expected Completion	Geography	Segment / Function	Charge	Source	Note
2024-12-31	acquisition_addition	completed		2024-03-31		United States	CAG (veterinary practice management software and data platform)	USD 81 (millions)	business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Acquisition of a privately-owned U.S. software and data platform business for approximately $81.1 million, including an estimated $4.4 million contingent payment; completed during Q1 2024. Headcount added through the acquisition is not disclosed.
2022-09-30	acquisition_addition	completed				Canada	Water		business_combinations_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Q3 2022 acquisition of an international water testing company for approximately $12.8 million in cash; no headcount added disclosed.
2022-09-30	divestiture_reduction	in_progress		2022-06		Russia	Other		MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML	Decision to wind down and liquidate the sole Russian subsidiary and direct Russian operations; liquidation basis of accounting adopted; no employee count disclosed. Announcement month only stated.
2021-12-31	acquisition_addition	completed				International	CAG — Veterinary Software and Services	USD 157 (millions)	business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Acquired during Q2 2021; consideration includes an estimated $5.0M contingent payment (later increased by $2.0M). Headcount added not disclosed; exact announcement date not stated.
2021-12-31	acquisition_addition	completed				Finland	CAG — Reference Laboratory Diagnostic and Consulting Services	USD 13 (millions)	business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Acquired during Q4 2021, including a holdback of approximately $1.4M. Headcount added not disclosed.
2021-12-31	acquisition_addition	completed				Switzerland	CAG — Reference Laboratory Diagnostic and Consulting Services	USD 6 (millions)	business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Acquired during Q1 2021, including holdback and contingent payments of approximately $1.1M. Headcount added not disclosed.
2021-12-31	acquisition_addition	completed				United States	CAG — Diagnostic Imaging / Teleradiology	USD 5 (millions)	business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Acquired during Q3 2021, including a contingent payment of $0.3M. Headcount added not disclosed.
2020-06-30	other	completed				Global	All segments		MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML	Temporary reductions to employee salaries and benefits and Board compensation were implemented in response to COVID-19 and later discontinued given improved business trends; no employee count or charge disclosed.
2019-12-31	acquisition_addition	completed		2019-10-07	2019-10-07	United States (Midwest)	CAG — reference laboratory	USD 50 (millions)	business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Cash purchase price of $50.0 million for assets of a multi-site reference laboratory business; headcount added not disclosed.
2019-12-31	other	completed	1	2019-10-23	2019-11-01	United States	Executive leadership (CEO transition)	USD 13 (millions)	MD&A f5-10k / MiMo-V2.6-Flash-fp8-HTML	Mutual separation agreement with former CEO; $13.4M operating charge for severance and equity award acceleration, $12.2M net of tax. New CEO appointed effective 2019-10-23.
2019-09-30	other	announced	1		2019-11-01	United States	Executive / Corporate	USD 13 (millions)	MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML	Mutual separation agreement with Jonathan W. Ayers (Chairman, former President and CEO, on medical leave since 2019-06-28): severance plus modification/acceleration of outstanding stock options; ~$13.4M operating charge and ~$2.1M tax provision increase (~$15.5M total) expected in Q4 2019. Effective transition date 2019-11-01; agreement announcement date not disclosed. Single-executive event, not a broad RIF.
2018-12-31	acquisition_addition	completed				United States	CAG — veterinary software	USD 25 (millions)	business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Q3 2018 acquisition of substantially all assets of a software company for $25.0 million; headcount added not disclosed.
2018-12-31	acquisition_addition	completed				United States	CAG — reference laboratory customer lists	USD 2 (millions)	business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Four reference laboratory customer-list asset acquisitions during 2018; treated as asset acquisitions, headcount added not disclosed.
2017-06-30	acquisition_addition	completed		2017-06-15		United States	Companion Animal Group (CAG)	USD 15 (millions)	business_combinations_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Acquisition of assets of two veterinary software companies ($15M: $12M at closing plus $3M contingent); no employee count disclosed. Preliminary purchase price allocation includes $13.1M goodwill.
2015-12-31	acquisition_addition	completed				United States; one business located outside the U.S.	CAG (Companion Animal Group) — reference laboratory diagnostic and consulting services		business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	During 2015 the company acquired the assets of two reference laboratory diagnostic and consulting businesses for $7.5 million cash plus $3.2 million contingent consideration; headcount added through these acquisitions was not disclosed.
2014-12-31	acquisition_addition	completed				United States and international (two of three cloud-based software businesses acquired outside the U.S.)	Companion Animal Group		business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Seven businesses acquired during FY2014 for an aggregate $25.1 million (purchase price, not a workforce charge); headcount added through these acquisitions is not disclosed.
2013-12-31	acquisition_addition	completed				Brazil	Livestock, Poultry and Dairy (LPD)		business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Acquired all outstanding shares of a Brazilian distributor of bovine and dairy test products for $10.8 million cash during Q3 2013; exact announcement/closing date not disclosed. Headcount added not disclosed; integration costs noted in LPD G&A expense.
2013-12-31	other	completed				North America	Companion Animal Group (CAG) — commercial/sales organization		Item_1_Business f5-10k / MiMo-V2.6-Flash-fp8-HTML	During 2013 the North American CAG sales organization was reorganized from specialty (in-clinic vs. reference lab) reps into all-modality account representatives, with an increase in sales force size and smaller territories. No headcount figures or charges disclosed; not a reduction in force.
2012-12-31	acquisition_addition	completed		2012			Companion Animal Group (CAG)		business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Three businesses acquired during 2012 for an aggregate $3.6 million in cash (including a product right); headcount added not disclosed. All acquired assets assigned to CAG.
2012-12-31	acquisition_addition	completed		2012-12		United States	Companion Animal Group (CAG) — Practice Management		Item_1_Business f5-10k / MiMo-V2.6-Flash-fp8-HTML	Acquisition of the assets of Sneakers Software, Inc. (DVMAX practice management software) in December 2012; headcount added not disclosed. May overlap with the three business combinations in Note 3.
2011-12-31	acquisition_addition	completed		2011-11-30		United States (Columbia, Missouri)	CAG — Reference Laboratory Diagnostic and Consulting Services	USD 43 (millions)	business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Acquisition of the RADIL research and diagnostic laboratory business from the University of Missouri College of Veterinary Medicine for $43.0 million cash; acquired headcount not disclosed. Filing also notes two other unnamed 2011 business acquisitions (aggregate cash paid for all three businesses was $46.8 million) with no headcount disclosed.
2011-03-31	restructuring	in_progress				United States	Companion Animal Group — reference laboratory diagnostic and consulting services		MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML	Severance charges from restructuring of transportation services cited as a driver of higher personnel costs; no employee count, charge amount, or timing disclosed.
2011-03-31	restructuring	completed					Reference laboratory diagnostic and consulting services		MD&A f5-10q / Qwen3.6-27B-Q8_0	Increased personnel costs due primarily to severance charges related to a restructuring of transportation services.
2009-12-31	acquisition_addition	completed		2009-08-31		United States (Oregon)	Companion Animal Group		business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	August 2009 acquisition of substantially all assets of VDIC, Inc., a telemedicine and cytopathology services provider; headcount added not disclosed.
2009-12-31	acquisition_addition	completed		2009-08-31		United States	Companion Animal Group		business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	August 2009 acquisition of certain assets of Pet Detect (temporary pet identification systems); headcount added not disclosed.
2009-12-31	restructuring	completed		2008-Q4	2008-12-31	Global	Pharmaceutical Division	USD 2 (millions)	MD&A f5-10k / Qwen3.6-27B-Q8_0	Restructuring of pharmaceutical division and sale of product lines. Pre-tax loss of approx $1.5M recognized in 2008.
2009-12-31	acquisition_addition	completed		2009-08-01	2009-08-31	United States	Companion Animal Group		business_combinations_footnote f5-10k / Qwen3.6-27B-Q8_0	Acquisition of VDIC, Inc. and Pet Detect assets in August 2009.
2008-12-31	divestiture_reduction	completed				United States	Companion Animal Group — Pharmaceutical product lines		restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Fourth quarter 2008 sale of Acarexx and SURPASS products plus one product under development for $7.0M cash, a $1.4M receivable, and up to $12.0M in milestones; no employee count disclosed. Combined pre-tax loss on the transactions and related restructuring was approximately $1.5M.
2008-12-31	restructuring	completed				United States	Pharmaceutical business (remaining product line and two out-licensing arrangements realigned to Other segment; two product lines realigned to Rapid Assay)	USD 2 (millions)	restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Pre-tax loss of approximately $1.5M covers both the disposition and the restructuring (S&M $0.263M, G&A $1.095M, R&D $0.121M); no headcount affected disclosed. A $2.1M tax provision was recorded, primarily on $7.2M of non-deductible goodwill allocated to the sold product lines.
2008-12-31	acquisition_addition	completed		2008-01-01		Spain	Companion Animal Group — Reference laboratory services		business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	January 2008 acquisition of substantially all assets of VetLab Laboratorio Veterinario de Referencia, S.L. (Barcelona); headcount added not disclosed. Total 2008 cash paid for a business and certain intangibles was $6.8M, with up to $7.7M of contingent milestone payments.
2008-12-31	restructuring	completed		2008-Q4	2008-12-31	Global	Pharmaceutical Business	USD 2 (millions)	MD&A f5-10k / Qwen3.6-27B-Q8_0	Restructuring of pharmaceutical business; loss on transaction and restructuring of approximately $1.5 million. Employee count not disclosed.
2008-09-30	restructuring	announced		2008-10-17	2008-12-31		Companion Animal Group — pharmaceutical business		subsequent_events f5-10q / MiMo-V2.6-Flash-fp8-HTML	Post-quarter agreement to sell ACAREXX and SURPASS products plus a product in development; company intends to restructure the remaining pharmaceutical business upon closing in Q4 2008. No employee count, charge, or completion date beyond Q4 2008 disclosed; impact not expected to be material to Q4 2008 results.
2007-12-31	acquisition_addition	completed		2007-01		United States	Other (OPTI Medical — human point-of-care diagnostics)		business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Acquired substantially all assets and assumed certain liabilities of the Critical Care Division of Osmetech plc; headcount added not disclosed
2007-12-31	acquisition_addition	completed		2007-03		Canada	CAG — veterinary reference laboratory services		business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Acquired all equity of Vita-Tech Canada Inc.; headcount added not disclosed
2007-12-31	acquisition_addition	completed		2007-03		France	PAS — production animal diagnostics		business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Acquired all equity of Institut Pourquier SAS; headcount added not disclosed
2007-12-31	acquisition_addition	completed		2007-03		United States	CAG — veterinary reference laboratory services		business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Veterinary reference laboratories acquired in March and October 2007, plus certain laboratory assets and customer lists acquired in the U.S., Switzerland and the United Kingdom; headcount added not disclosed
2007-12-31	acquisition_addition	completed		2007-10		Canada	CAG — veterinary reference laboratory services		business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Veterinary reference laboratories acquired in Canada during 2007; headcount added not disclosed
2007-09-30	acquisition_addition	completed		2007-01-01		United States	OPTI Medical		business_combinations_footnote f5-10q / Qwen3.6-27B-Q8_0	Acquired substantially all assets of Critical Care Division of Osmetech plc in Jan 2007. Headcount not disclosed.
2007-09-30	acquisition_addition	completed		2007-03-01		Canada	Companion Animal Group		business_combinations_footnote f5-10q / Qwen3.6-27B-Q8_0	Acquired Vita-Tech Canada Inc. in Mar 2007. Headcount not disclosed.
2007-09-30	acquisition_addition	completed		2007-03-01		France	Production Animal Segment		business_combinations_footnote f5-10q / Qwen3.6-27B-Q8_0	Acquired Institut Pourquier SAS in Mar 2007. Headcount not disclosed.
2007-06-30	acquisition_addition	completed		2007-01-01		United States	OPTI Medical		business_combinations_footnote f5-10q / Qwen3.6-27B-Q8_0	Acquired substantially all assets and liabilities of Critical Care Division of Osmetech plc in January 2007. Headcount not disclosed.
2007-06-30	acquisition_addition	completed		2007-03-01		Canada	Companion Animal Group		business_combinations_footnote f5-10q / Qwen3.6-27B-Q8_0	Acquired all equity of Vita-Tech Canada Inc. in March 2007. Headcount not disclosed.
2007-06-30	acquisition_addition	completed		2007-03-01		France	Production Animal Segment		business_combinations_footnote f5-10q / Qwen3.6-27B-Q8_0	Acquired all equity of Institut Pourquier SAS in March 2007. Headcount not disclosed.
2007-06-30	acquisition_addition	completed		2007-03-01		United States	Companion Animal Group		business_combinations_footnote f5-10q / Qwen3.6-27B-Q8_0	Acquired veterinary reference laboratory based in North Carolina in March 2007. Headcount not disclosed.
2007-06-30	acquisition_addition	completed		2007-04-01		Switzerland	Companion Animal Group		business_combinations_footnote f5-10q / Qwen3.6-27B-Q8_0	Acquired certain assets of a veterinary reference laboratory based in Switzerland in April 2007. Headcount not disclosed.
2007-03-31	acquisition_addition	completed		2007-01-31		United States	OPTI Medical (Other segment)		business_combinations_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Acquired substantially all assets and liabilities of Osmetech plc's Critical Care Division in January 2007; headcount added not disclosed.
2007-03-31	acquisition_addition	completed		2007-03-31		Canada	Companion Animal Group (CAG)		business_combinations_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Acquired all equity of Vita-Tech Canada Inc. in March 2007; headcount added not disclosed.
2007-03-31	acquisition_addition	completed		2007-03-31		France	Production Animal Segment (PAS)		business_combinations_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Acquired all equity of Institut Pourquier in March 2007; headcount added not disclosed.
2007-03-31	acquisition_addition	completed		2007-03-31		United States	Companion Animal Group (CAG)		business_combinations_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Acquired a veterinary reference laboratory based in North Carolina in March 2007; headcount added not disclosed.
2007-03-31	acquisition_addition	completed		2007-01-01		United States	OPTI Medical		business_combinations_footnote f5-10q / Qwen3.6-27B-Q8_0	Acquired substantially all assets and liabilities of Critical Care Division of Osmetech plc in January 2007. Headcount not disclosed.
2007-03-31	acquisition_addition	completed		2007-03-01		Canada	Companion Animal Group		business_combinations_footnote f5-10q / Qwen3.6-27B-Q8_0	Acquired all equity of Vita-Tech Canada Inc. in March 2007. Headcount not disclosed.
2007-03-31	acquisition_addition	completed		2007-03-01		France	Production Animal Segment		business_combinations_footnote f5-10q / Qwen3.6-27B-Q8_0	Acquired Institut Pourquier in March 2007. Headcount not disclosed.
2007-03-31	acquisition_addition	completed		2007-03-01		United States	Companion Animal Group		business_combinations_footnote f5-10q / Qwen3.6-27B-Q8_0	Acquired a veterinary reference laboratory based in North Carolina in March 2007. Headcount not disclosed.
2006-12-31	acquisition_addition	completed		2007-01-31	2007-01-31	United States	OPTI Medical Systems (human point-of-care diagnostics)	USD 45 (millions)	subsequent_events f5-10k / MiMo-V2.6-Flash-fp8-HTML	Acquisition of the Critical Care Division of Osmetech plc closed 2007-01-31 for approximately $45 million cash; creates a new operating segment. Headcount added not disclosed.
2006-12-31	acquisition_addition	announced		2007-01-26	2007-03-31	France	Production Animal Segment		subsequent_events f5-10k / MiMo-V2.6-Flash-fp8-HTML	Agreement to acquire all shares of Institut Pourquier (Montpellier), announced 2007-01-26, expected to close March 2007; target had approximately $7.5 million of 2006 sales. Headcount not disclosed.
2006-12-31	acquisition_addition	completed		2006-04-30	2006-04-30	China	Production Animal Segment	USD 1 (millions)	restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Step acquisition: paid $0.6 million for an additional 55% equity interest in a China production animal diagnostics joint venture (April 2006), with a further $0.2 million payable over two years. Headcount not disclosed.
2006-12-31	acquisition_addition	completed				United States; Canada; South Africa; Australia	Companion Animal Group	USD 24 (millions)	business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	FY2006 acquisitions comprised veterinary reference laboratories in the U.S., Canada and South Africa, a U.S. practice information management software business, and IP/distribution rights from an Australian diagnostics company; $23.9 million cash paid during 2006. Headcount added not disclosed.
2006-03-31	acquisition_addition	completed		2006-02		United States	Companion Animal Group	USD 1 (millions)	business_combinations_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Cash purchase of certain assets of a U.S. veterinary reference laboratory; no headcount disclosed. Additional contingent payment of up to $0.1 million tied to milestones.
2006-03-31	acquisition_addition	announced			2006-05	China	Veterinary diagnostics joint venture (production animals)	USD 1 (millions)	other f5-10q / MiMo-V2.6-Flash-fp8-HTML	Agreement to buy an additional 55% equity interest in a China joint venture; Chinese government approvals obtained in April 2006, purchase expected to close in May 2006 with a $0.6 million payment. No headcount disclosed.
2005-12-31	plant_closure	completed		2005-12-31	2005-12-31	Sweden	Food Diagnostics Group — European production animal diagnostics manufacturing	USD 1 (millions)	restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	During 2005 the company centralized European production animal diagnostics manufacturing in Bern, Switzerland and ceased its Sweden-based operation. The $1.0M charge comprises a $0.5M cumulative translation write-off, $0.4M of employee termination benefits, and $0.1M of lease termination costs. No employee headcount affected is disclosed; no future costs expected.
2005-12-31	acquisition_addition	completed		2005-12-31	2005-12-31	Switzerland, United Kingdom, Germany, France, United States	Companion Animal Group — veterinary reference laboratories and customer lists		business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	In 2005 the company paid $5.5M cash and assumed $0.7M of liabilities to acquire veterinary reference laboratory assets in Switzerland, the UK, Germany and France plus customer lists in the U.S. and Germany. Headcount acquired is not disclosed.
2005-12-31	acquisition_addition	completed		2005-09-30	2005-09-30	United States (Georgia)	Companion Animal Group — practice information management and digital radiography systems		business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	September 2005 acquisition of a Georgia-based veterinary-specific digital radiography business for $2.0M cash plus assumed liabilities of $1.3M, with up to $2.3M of contingent milestone payments. Headcount acquired is not disclosed.
2005-12-31	restructuring	completed		2005	2005-12-31	Sweden	Food Diagnostics Group	USD 0 (millions)	restructuring_footnote f5-10k / Qwen3.6-27B-Q8_0	Centralization of European production animal diagnostics operations in Bern, Switzerland; cessation of operations in Sweden. Includes one-time employee termination benefits of $0.2 million.
2005-12-31	acquisition_addition	completed		2005-09	2005-09	United States	Companion Animal Group		business_combinations_footnote f5-10k / Qwen3.6-27B-Q8_0	Acquisition of Georgia-based veterinary-specific digital radiography systems company.
2005-12-31	acquisition_addition	completed		2005	2005-12-31	Switzerland, United Kingdom, Germany, France	Companion Animal Group		business_combinations_footnote f5-10k / Qwen3.6-27B-Q8_0	Acquisition of certain assets of veterinary reference laboratories.
2005-09-30	acquisition_addition	completed		2005-03-31		Switzerland	Companion Animal Group	USD 1 (millions)	business_combinations_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Cash purchase of certain assets of a veterinary reference laboratory; filing discloses purchase price but no employee counts.
2005-09-30	acquisition_addition	completed		2005-09-30		United Kingdom, Germany, United States (Virginia and Georgia)	Companion Animal Group	USD 6 (millions)	business_combinations_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Four acquisitions during the quarter: three veterinary reference laboratories plus a Georgia digital radiography seller; $5.7M cash paid and $1.7M liabilities assumed, with up to $2.3M contingent milestone payments. No headcount added disclosed.
2005-03-31	acquisition_addition	completed		2005-03-31		Switzerland	Companion Animal Group	USD 1 (millions)	business_combinations_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Cash purchase of certain assets of a Swiss veterinary reference laboratory; goodwill $0.2M and intangibles $0.2M assigned to CAG. No employee count disclosed.
2005-03-31	restructuring	in_progress			2005-09-30	Sweden	Food Diagnostics Group		MD&A f5-10q / Qwen3.6-27B-Q8_0	Severance costs associated with cessation of production in Swedish facility and centralization of European operations to Bern, Switzerland.
2004-12-31	acquisition_addition	completed		2004-02		United States (Ohio)	Companion Animal Group — veterinary reference laboratories	USD 7 (millions)	business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Total purchase price of $6.8 million ($5.3M cash, $1.0M note, $0.5M assumed liabilities); acquired headcount not disclosed.
2004-12-31	acquisition_addition	completed		2004-08		United States (New York)	Food Diagnostics Group — production animal diagnostics	USD 2 (millions)	business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	All shares acquired for $1.5 million cash; acquired headcount not disclosed.
2004-12-31	acquisition_addition	completed		2004-11		Germany (with operations in Switzerland, Netherlands, UK, France, Italy, Austria, Denmark)	Companion Animal Group — veterinary reference laboratories (Vet Med Lab)	USD 42 (millions)	business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Total purchase price of $42.3 million ($31.3M cash net of cash acquired, $11.5M assumed liabilities, $0.5M adjustment receivable); acquired headcount not disclosed. Largest European veterinary reference laboratory.
2004-12-31	acquisition_addition	completed		2004-12		Switzerland	Food Diagnostics Group — production animal diagnostics (Dr. Bommeli AG)	USD 19 (millions)	business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Total purchase price of $18.9 million ($15.8M cash net of cash acquired, $3.1M assumed liabilities); acquired headcount not disclosed.
2004-09-30	acquisition_addition	completed		2004-02	2004-02	United States (Ohio)	Companion Animal Group	USD 7 (millions)	business_combinations_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Acquisition of assets and assumed liabilities of a veterinary reference laboratory; $5.8M assigned to goodwill and intangibles. No employee count disclosed.
2004-09-30	acquisition_addition	completed		2004-08	2004-08	United States (New York)	Food Diagnostics Group	USD 2 (millions)	business_combinations_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Cash acquisition of all shares of a production animal diagnostics company; $2.1M intangible assets assigned to FDG. No employee count disclosed.
2004-09-30	acquisition_addition	completed		2004-11	2004-11	Germany and Switzerland (operations also in Netherlands, United Kingdom, Italy, Austria, Denmark)	Companion Animal Group (commercial veterinary laboratories)	USD 31 (millions)	subsequent_events f5-10q / MiMo-V2.6-Flash-fp8-HTML	Post-quarter cash acquisition of Institut für klinische Prüfung Ludwigsburg GmbH; purchase price subject to adjustment and excludes direct acquisition costs. No employee count disclosed.
2004-09-30	acquisition_addition	announced		2004-09-30	2004-12-31	Switzerland	Food Diagnostics Group (production animal diagnostics)	USD 16 (millions)	subsequent_events f5-10q / MiMo-V2.6-Flash-fp8-HTML	Agreement to acquire all shares of Dr. Bommeli AG, pending regulatory approval; expected completion within 2004. No employee count disclosed.
2004-03-31	other	completed							MD&A f5-10q / Qwen3.6-27B-Q8_0	Severance benefits provided in 2004 resulted in a $0.1 million increase in operating expenses for the 'Other' segment.
2004-03-31	acquisition_addition	completed		2004-02		Ohio	Companion Animal Group	USD 7 (millions)	business_combinations_footnote f5-10q / Qwen3.6-27B-Q8_0	Acquired assets and liabilities of a veterinary reference laboratory in Ohio for $6.8 million. Headcount added is not explicitly disclosed.
2003-12-31	restructuring	completed		2003-10-16	2003-12-31		Companion Animal Group — research and development	USD 7 (millions)	other f5-10k / MiMo-V2.6-Flash-fp8-HTML	Following the October 2003 Ortho supply agreement, the company discontinued development of an alternative clinical chemistry instrument and took a non-cash write-down of manufacturing equipment in Q4 2003. No headcount impact disclosed.
2003-12-31	acquisition_addition	completed				United States — Kentucky	Companion Animal Group — veterinary reference laboratories		MD&A f5-10k / MiMo-V2.6-Flash-fp8-HTML	Laboratory acquired in the third quarter of 2003; headcount added not disclosed.
2003-12-31	acquisition_addition	completed				United States — Ohio	Companion Animal Group — veterinary reference laboratories		MD&A f5-10k / MiMo-V2.6-Flash-fp8-HTML	Columbus, Ohio laboratory acquired in the first quarter of 2004, after fiscal year-end; headcount added not disclosed.
2003-12-31	other	completed					Companion Animal Group		MD&A f5-10k / MiMo-V2.6-Flash-fp8-HTML	Company terminated a low-margin veterinary referral business during 2003; no headcount or charge disclosed.
2002-12-31	voluntary_separation	completed		2001-10-01	2002-01-31	United States	Corporate / Executive	USD 3 (millions)	restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Retirement of Founder/Chairman/CEO in January 2002 under an October 2001 employment agreement; pre-tax charge of $3.4M, of which $1.8M non-cash; $0.9M remained accrued at 2002-12-31. Affects a single executive; no broader headcount reduction disclosed.
2002-12-31	restructuring	completed		2002-01-01	2002-12-31	Global	Executive Management	USD 3 (millions)	MD&A f5-10k / Qwen3.6-27B-Q8_0	Charges related to CEO succession and retirement of Founder. Includes $1.8 million non-cash portion.
2002-09-30	other	in_progress		2002-01		Not specified	Corporate — Chief Executive Officer	USD 3 (millions)	other f5-10q / MiMo-V2.6-Flash-fp8-HTML	Founder/Chairman/CEO succeeded in January 2002; payments and benefits due under his employment agreement. Pre-tax charges of $2.9M (Q1) and $0.5M (Q2) totaled $3.4M for the nine months ended September 30, 2002, of which $1.8M was non-cash. No charges incurred in Q3 2002; no employee count stated.
2002-09-30	other	completed		2002-01-01			Executive Management	USD 3 (millions)	other f5-10q / Qwen3.6-27B-Q8_0	Charges related to CEO succession and retirement benefits for former CEO. Includes $1.8 million non-cash portion.
2001-12-31	acquisition_addition	completed		2000-07-01	2000-07-01	Australia	Companion Animal Group — veterinary reference laboratories		business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Acquisition of Veterinary Pathology Services Pty. Ltd. completed July 1, 2000; results included in 2001 comparative period. Headcount added not disclosed.
2001-12-31	acquisition_addition	completed		2000-08-11	2000-08-11	United Kingdom	Food and Environmental Division — water testing		business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Acquired for $8.9M cash and $8.3M notes; headcount added not disclosed. Completed August 11, 2000.
2001-12-31	divestiture_reduction	completed		1999-12-21	2000-02-29	United States	Food and Environmental Division — food microbiology testing		discontinued_operations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Food microbiology testing businesses sold December 1999 and February 2000; headcount removed not disclosed. Net gain $1.5M recorded in 2000.
2001-12-31	other	announced		2002-01-31	2002-03-31	United States	Corporate — executive succession	USD 3 (millions)	subsequent_events f5-10k / MiMo-V2.6-Flash-fp8-HTML	Founder David E. Shaw succeeded by Jonathan W. Ayers as Chairman and CEO in January 2002; pre-tax charge of ~$3.0M ($2.0M non-cash) to be recorded in Q1 2002 under October 2001 agreement. Not a headcount reduction.
2001-12-31	restructuring	completed		2000		United States	Companion Animal Group	USD 2 (millions)	MD&A f5-10k / Qwen3.6-27B-Q8_0	Non-recurring severance and facilities expenses associated with consolidation of Internet business and veterinary practice information management software systems. Discussed in 2000 vs 1999 comparison, but expense recognized in 2000. No specific headcount disclosed.
2001-03-31	restructuring	in_progress				United States	Companion Animal Group — veterinary Internet portal and customer service operations		MD&A f5-10q / MiMo-V2.6-Flash-fp8-HTML	MD&A cites non-recurring severance expenses tied to infrastructure reductions in the veterinary Internet portal and customer service operations; no employee count, charge amount, or timing disclosed.
2001-03-31	restructuring	completed					Companion Animal Group		MD&A f5-10q / Qwen3.6-27B-Q8_0	Non-recurring severance expenses associated with infrastructure reductions in veterinary Internet portal and customer service operations.
2000-12-31	divestiture_reduction	completed		1999-12-21		United States	Food and Environmental Division — food laboratory testing services		discontinued_operations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Substantially all assets sold for $350,000 cash plus a $195,000 note; headcount not disclosed. Net loss of approximately $400,000 recorded in 1999 across the divestiture series.
2000-12-31	divestiture_reduction	completed		2000-02-16		United States	Food and Environmental Division — food microbiology testing products		discontinued_operations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Sale of Lightning, Simplate and Bind product lines plus Acumedia subsidiary for $10.4 million cash; headcount not disclosed. MD&A notes a $1.5 million gain recorded as a decrease of expenses in 2000.
2000-12-31	acquisition_addition	completed		2000-03-09		United States — Los Angeles, California	Companion Animal Group — veterinary reference laboratory services		business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Sierra Veterinary Laboratory LLC acquired; headcount added not disclosed. Part of $3.4 million aggregate purchase price for two 2000 laboratory acquisitions, plus contingent future payments over four years.
2000-12-31	acquisition_addition	completed		2000-07-01		Australia — Adelaide, Brisbane, Sydney	Companion Animal Group — veterinary reference laboratory services		business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Veterinary Pathology Services Pty. Ltd. acquired; headcount added not disclosed. Included in the $3.4 million aggregate 2000 laboratory purchase price.
2000-12-31	acquisition_addition	completed		2000-08-11		United Kingdom	Food and Environmental Division — water testing (cryptosporidia)		business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Acquired for $8.9 million cash plus $8.3 million in notes to the former principal shareholder; headcount added not disclosed.
2000-12-31	restructuring	in_progress				United States	Companion Animal Group — Internet business (VetConnect) and veterinary practice information management systems business	USD 2,056 (thousands)	MD&A f5-10k / MiMo-V2.6-Flash-fp8-HTML	Non-recurring severance and facilities expenses for consolidating the Internet and practice-management software businesses; $2,056 thousand charged to costs and expenses in 2000, leaving a $1,904 thousand accrual at year-end. Filer states additional costs are expected in 2001. Employees affected not disclosed.
2000-12-31	restructuring	completed		2000		United States	Internet business and veterinary practice information management systems		MD&A f5-10k / Qwen3.6-27B-Q8_0	Company incurred non-recurring severance and facilities expenses associated with consolidation of the Internet business and the veterinary practice information management systems business. Specific headcount not disclosed.
1999-12-31	restructuring	in_progress				United States	Sales and Marketing		MD&A f5-10k / MiMo-V2.6-Flash-fp8-HTML	MD&A attributes 1999 sales and marketing expense decline partly to workforce reductions; no headcount or charge quantified for 1999
1999-12-31	divestiture_reduction	completed			2000-02-29	United States	Food and Environmental Division — food microbiology testing	USD 0 (millions)	discontinued_operations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Food microbiology business sold via transactions in Dec 1999 and Feb 2000; $400K loss recorded in 1999; no headcount disclosed
1999-12-31	acquisition_addition	completed			1999-03-31	United States — Arizona	Companion Animal Group — veterinary reference laboratory		business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Acquisition of Sonora Quest Laboratories veterinary lab business; purchase price $4.1M aggregate for two 1999 lab acquisitions; no headcount disclosed
1999-12-31	acquisition_addition	completed			1999-12-01	United States — Massachusetts	Companion Animal Group — veterinary reference laboratory		business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Acquisition of Tufts University School of Veterinary Medicine lab business; no headcount disclosed
1999-12-31	restructuring	completed	228	1997		Global	Various (Sales, Marketing, R&D, Management)	USD 21 (millions)	restructuring_footnote f5-10k / Qwen3.6-27B-Q8_0	Workforce reduction occurred in 1997. Charge included severance, idle capacity, lease termination, and asset impairment. As of Dec 31, 1999, $653k remained in accrued expenses for severance and lease payments.
1999-09-30	restructuring	in_progress				Europe	Distribution	USD 1 (millions)	restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0	Balance remaining at Sept 30, 1999 primarily represents severance payments due to terminated employees, unpaid charges related to consolidation and relocation of distribution functions in Europe and lease payments on unutilized facilities.
1999-06-30	restructuring	in_progress				Europe	Distribution	USD 2 (millions)	restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0	Accrued expenses of $2.0 million remain from 1997 workforce reduction; includes severance, consolidation of distribution functions in Europe, and lease payments on unutilized facilities.
1999-03-31	restructuring	in_progress		1997		Europe	Distribution	USD 2 (millions)	restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0	Accrued expenses of $2.3 million remain from a 1997 workforce reduction and consolidation of distribution functions in Europe. Includes severance and lease payments.
1999-03-31	acquisition_addition	completed		1999-03-31		Phoenix, Arizona	Veterinary Services	USD 1 (millions)	business_combinations_footnote f5-10q / Qwen3.6-27B-Q8_0	Acquired veterinary laboratory business for $1.3 million cash and $539,000 note. Headcount not disclosed.
1999-03-31	acquisition_addition	completed		1998-10-01		Greensboro, North Carolina	Pharmaceuticals	USD 39 (millions)	business_combinations_footnote f5-10q / Qwen3.6-27B-Q8_0	Acquired Blue Ridge Pharmaceuticals for approx $39.1 million cash, $7.8 million notes, and stock. Headcount not disclosed.
1998-12-31	acquisition_addition	completed		1998-10-01	1998-10-01	United States	Other (Blue Ridge Pharmaceuticals)	USD 60 (millions)	business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Blue Ridge Pharmaceuticals acquired Oct 1, 1998 for ~$59.5M total purchase price; employee headcount added not disclosed. Purchase price included $37.2M in-process R&D write-off and $20.1M goodwill.
1998-12-31	restructuring	completed	228	1997-01-01	1997-12-31	Global	Various	USD 9 (millions)	restructuring_footnote f5-10k / Qwen3.6-27B-Q8_0	Workforce reduction occurred in 1997. Severance benefits and related costs were $9.0 million. Total employees terminated: 228 (79 software consolidation, 57 Europe sales/marketing, 33 domestic sales/marketing, 18 Asia-Pacific sales/marketing, 16 Sunnyvale R&D closure, 25 management/finance).
1998-12-31	acquisition_addition	completed		1998-10-01	1998-10-01	United States	Veterinary Pharmaceuticals		business_combinations_footnote f5-10k / Qwen3.6-27B-Q8_0	Acquired Blue Ridge Pharmaceuticals, Inc. on October 1, 1998. Specific headcount added not disclosed in filing.
1998-09-30	restructuring	in_progress	79			United States (Eau Claire, Wisconsin)	Veterinary practice management software		restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Terminations tied to consolidating veterinary practice management software operations into the Eau Claire facility; part of a 228-employee program initiated in 1997.
1998-09-30	restructuring	in_progress	57		1998-12-31	Europe	Sales, marketing and distribution operations		restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Only remaining component of the severance program; European facility consolidation scheduled for Q4 1998.
1998-09-30	restructuring	completed	33			United States	Sales and marketing		restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Reductions in domestic sales and marketing operations; severance program essentially complete as of 1998-09-30.
1998-09-30	restructuring	completed	18			Pacific Rim	Sales and marketing		restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Reductions in sales and marketing operations in the Pacific Rim region.
1998-09-30	plant_closure	completed	16			United States (Sunnyvale, California)	Research and development		restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Closure of the leased Sunnyvale R&D facility; excess lease obligations and $1.6M of abandoned immunoassay fixed assets and license fees also recorded.
1998-09-30	restructuring	completed	25			United States	Management and financial operations		restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Reduction in management and financial operations positions.
1998-09-30	acquisition_addition	completed		1998-03-01	1998-03-01	United States (Texas)	Food safety testing laboratory	USD 0 (millions)	business_combinations_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Agri-West Laboratory acquired for approximately $250,000 cash; headcount added not disclosed. Charge value reflects purchase price, not a workforce charge.
1998-09-30	acquisition_addition	completed		1998-10-01	1998-10-01	United States (Greensboro, North Carolina)	Veterinary pharmaceuticals	USD 39 (millions)	subsequent_events f5-10q / MiMo-V2.6-Flash-fp8-HTML	Blue Ridge Pharmaceuticals acquired after quarter end for $39.1M cash plus $7.8M notes, 114,894 shares and warrants; up to 1,240,875 additional shares contingent on operating targets through 2004. Headcount added not disclosed; charge value reflects cash consideration.
1998-09-30	restructuring	in_progress	79	1997-09-30	1998-12-31	Eau Claire, Wisconsin	Veterinary practice management software		restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0	Consolidation of veterinary practice management software business into Eau Claire facility.
1998-09-30	restructuring	in_progress	57	1997-09-30	1998-12-31	Europe	Sales, marketing and distribution		restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0	Consolidation of sales, marketing and distribution operations in Europe scheduled for Q4 1998.
1998-09-30	restructuring	completed	33	1997-09-30		United States	Domestic sales and marketing		restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0	Reductions in domestic sales and marketing operations.
1998-09-30	restructuring	completed	18	1997-09-30		Pacific Rim	Sales and marketing		restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0	Reductions in sales and marketing operations in the Pacific Rim region.
1998-09-30	plant_closure	completed	16	1997-09-30		Sunnyvale, California	Research and development		restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0	Closure of the Sunnyvale, California research and development facility.
1998-09-30	restructuring	completed	25	1997-09-30		United States	Management and financial operations		restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0	Reduction in positions in management and financial operations.
1998-06-30	restructuring	completed	79	1997		United States (Eau Claire, Wisconsin)	Veterinary practice management software		restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Employees terminated in connection with consolidating veterinary practice management software operations into the Eau Claire facility. Severance program essentially complete as of June 30, 1998. Program-wide severance, benefits and related costs totaled $9.0 million; not allocated by component.
1998-06-30	restructuring	in_progress	57	1997	1998-12-31	Europe	Sales, marketing and distribution operations		restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Only remaining open element of the severance program: consolidation of European facilities scheduled for the fourth quarter of 1998.
1998-06-30	reduction_in_force	completed	33	1997		United States	Sales and marketing		restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Positions reduced in domestic sales and marketing operations as part of the 1997 non-recurring operating charge workforce reduction.
1998-06-30	reduction_in_force	completed	18	1997		Pacific Rim	Sales and marketing		restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Positions reduced in Pacific Rim sales and marketing operations as part of the 1997 workforce reduction program.
1998-06-30	plant_closure	completed	16	1997		United States (Sunnyvale, California)	Research and development		restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Closure of the leased Sunnyvale, California research and development facility; excess lease obligations and idle capacity costs were included in the non-recurring charge.
1998-06-30	reduction_in_force	completed	25	1997		United States	Management and financial operations		restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Reduction in management and financial operations positions as part of the 1997 workforce reduction program; components sum to the disclosed program total of 228 terminated employees.
1998-06-30	acquisition_addition	completed		1998-03-01		United States (Texas)	Food safety testing laboratory services		business_combinations_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Agri-West Laboratory acquired for approximately $250,000 cash; acquired headcount not disclosed.
1998-06-30	restructuring	in_progress	79	1997-09-30	1998-12-31	Eau Claire, Wisconsin	Veterinary practice management software		restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0	Consolidation of veterinary practice management software business into Eau Claire facility. Part of 1997 workforce reduction.
1998-06-30	restructuring	in_progress	57	1997-09-30	1998-12-31	Europe	Sales, marketing and distribution		restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0	Consolidation of sales, marketing and distribution operations in Europe scheduled for fourth quarter 1998.
1998-06-30	restructuring	completed	33	1997-09-30		United States	Domestic sales and marketing		restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0	Reductions in domestic sales and marketing operations. Severance program essentially complete as of June 30, 1998.
1998-06-30	restructuring	completed	18	1997-09-30		Pacific Rim	Sales and marketing		restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0	Reductions in sales and marketing operations in the Pacific Rim region. Severance program essentially complete as of June 30, 1998.
1998-06-30	plant_closure	completed	16	1997-09-30		Sunnyvale, California	Research and development		restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0	Closure of Sunnyvale, California research and development facility. Severance program essentially complete as of June 30, 1998.
1998-06-30	restructuring	completed	25	1997-09-30			Management and financial operations		restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0	Reduction in positions in management and financial operations. Severance program essentially complete as of June 30, 1998.
1998-03-31	restructuring	in_progress	79	1997	1998-09-30	United States (Eau Claire, Wisconsin)	Veterinary practice management software		restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Consolidation of veterinary practice management software business into Eau Claire facility. Part of a 228-employee program with $9.0M total severance charge; charge not allocated by sub-component.
1998-03-31	restructuring	in_progress	57	1997	1998-09-30	Europe	Sales, marketing and distribution operations		restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Consolidation of European sales, marketing and distribution operations. Part of a 228-employee program with $9.0M total severance charge; charge not allocated by sub-component.
1998-03-31	reduction_in_force	in_progress	33	1997	1998-09-30	United States	Sales and marketing		restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Reductions in domestic sales and marketing operations. Part of a 228-employee program with $9.0M total severance charge; charge not allocated by sub-component.
1998-03-31	reduction_in_force	in_progress	18	1997	1998-09-30	Pacific Rim	Sales and marketing		restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Reductions in Pacific Rim sales and marketing operations. Part of a 228-employee program with $9.0M total severance charge; charge not allocated by sub-component.
1998-03-31	plant_closure	in_progress	16	1997	1998-09-30	United States (Sunnyvale, California)	Research and development		restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Closure of leased Sunnyvale, California R&D facility. Part of a 228-employee program with $9.0M total severance charge; charge not allocated by sub-component.
1998-03-31	reduction_in_force	in_progress	25	1997	1998-09-30	United States	Management and financial operations		restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Reductions in management and financial operations positions. Part of a 228-employee program with $9.0M total severance charge; charge not allocated by sub-component.
1998-03-31	restructuring	in_progress	228	1997	1998-09-30	Global	Various (Software, Sales, R&D, Management)	USD 9 (millions)	restructuring_footnote f5-10q / Qwen3.6-27B-Q8_0	Total of 228 employees terminated in 1997. As of March 31, 1998, 110 had left; remainder expected to leave in Q2 and Q3 1998. Severance charge was $9.0 million.
1998-03-31	acquisition_addition	completed		1998-03-01	1998-03-01	Texas	Food Testing	USD 0 (millions)	business_combinations_footnote f5-10q / Qwen3.6-27B-Q8_0	Acquired Agri-West Laboratory for approximately $250,000 in cash. Headcount not disclosed.
1997-12-31	restructuring	in_progress	79	1997-09-29	1998-06-30	United States	Veterinary Practice Management Software		restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Consolidation of veterinary practice management software business into Eau Claire, Wisconsin facility; part of $9.0M total severance charge.
1997-12-31	restructuring	in_progress	57	1997-09-29	1998-06-30	Europe	Sales, Marketing and Distribution		restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Consolidation of European sales, marketing and distribution operations; part of $9.0M total severance charge.
1997-12-31	restructuring	in_progress	33	1997-09-29	1998-06-30	United States	Sales and Marketing		restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Reductions in domestic sales and marketing operations; part of $9.0M total severance charge.
1997-12-31	restructuring	in_progress	18	1997-09-29	1998-06-30	Pacific Rim	Sales and Marketing		restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Reductions in Pacific Rim sales and marketing operations; part of $9.0M total severance charge.
1997-12-31	plant_closure	in_progress	16	1997-09-29	1998-06-30	United States	Research and Development		restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Closure of leased Sunnyvale, California research and development facility; part of $9.0M total severance charge.
1997-12-31	restructuring	in_progress	25	1997-09-29	1998-06-30	United States	Management and Financial Operations		restructuring_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Reduction in management and financial operations positions; part of $9.0M total severance charge.
1997-12-31	restructuring	in_progress	228	1997-09-29	1998-06-30	United States, Europe, Pacific Rim	Veterinary practice management software, veterinary laboratory, sales and marketing, R&D, management and financial operations	USD 9 (millions)	restructuring_footnote f5-10k / Qwen3.6-27B-Q8_0	Total non-recurring charge was $34.5 million. Severance portion was $9.0 million. 40 employees terminated by year-end; remainder expected to leave in first half of 1998.
1997-09-30	restructuring	in_progress		1997-09-29		Europe	European operations		restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Part of a ~$9 million charge covering European facility closures, European workforce reduction, and US veterinary operations workforce reduction; filer does not allocate the $9 million between sub-components or disclose employee counts.
1997-09-30	restructuring	in_progress		1997-09-29		United States	US veterinary operations		restructuring_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Same ~$9 million program as the European component; no employee count or separate charge allocation disclosed.
1997-09-30	acquisition_addition	completed		1997-01-30		United States	Manufacturing (dehydrated culture media)		business_combinations_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Acquisition of Acumedia Manufacturers, Inc.; no headcount added disclosed.
1997-09-30	acquisition_addition	completed		1997-03-13		United States	Veterinary practice management software	USD 11 (millions)	business_combinations_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	National Information Systems Corporation acquisition; part of ~$11.0 million in-process R&D write-off shared with Professionals' Software; no headcount added disclosed.
1997-09-30	acquisition_addition	completed		1997-07-01		Taiwan	Distribution		business_combinations_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Acquisition of certain assets and business rights of Wintek Bio-Science Inc.; no headcount added disclosed.
1997-09-30	acquisition_addition	completed		1997-07-18		United States	Veterinary practice management software	USD 11 (millions)	business_combinations_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Professionals' Software, Inc. acquisition; shares the ~$11.0 million in-process R&D write-off with National Information Systems; no headcount added disclosed.
1997-09-30	restructuring	announced		1997-09-29		Europe and United States	European operations and US veterinary operations	USD 9 (millions)	MD&A f5-10q / Qwen3.6-27B-Q8_0	Plan to close certain European facilities, reduce workforce in European and US veterinary operations. Employee count not disclosed.
1997-06-30	acquisition_addition	completed		1997-01-30	1997-01-30	United States (Baltimore, Maryland)	Manufacturing (dehydrated culture media)		business_combinations_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Acquisition of all capital stock of Acumedia Manufacturers, Inc.; headcount added not disclosed. Aggregate 1997 acquisition purchase prices approx. $9.9M cash plus $1.5M note.
1997-06-30	acquisition_addition	completed		1997-03-13	1997-03-13	United States (Eau Claire, Wisconsin)	Software (veterinary practice management systems)		business_combinations_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Acquisition of all capital stock of National Information Systems Corporation; headcount added not disclosed.
1997-06-30	acquisition_addition	announced		1997-07-01	1997-07-01	Taiwan (Taipei)	Distribution (veterinary diagnostic products)		subsequent_events f5-10q / MiMo-V2.6-Flash-fp8-HTML	Acquisition of certain assets and rights of Wintek Bio-Science Inc. for part of approx. $13.5M total subsequent-event cash consideration; headcount added not disclosed.
1997-06-30	acquisition_addition	announced		1997-07-18	1997-07-18	United States (Effingham, Illinois)	Software (veterinary practice management systems)		subsequent_events f5-10q / MiMo-V2.6-Flash-fp8-HTML	Acquisition of all capital stock of Professionals' Software, Inc.; headcount added not disclosed.
1996-12-31	acquisition_addition	completed		1996-03-29	1996-03-29	United States (Texas)	Veterinary laboratory services		business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Acquisition of all capital stock of VetLab, Inc.; part of aggregate ~$19.3M purchase price for four vet lab businesses; employee counts not disclosed
1996-12-31	acquisition_addition	completed		1996-04-02	1996-04-02	United Kingdom	Veterinary laboratory services		business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Acquisition of assets of Grange Laboratories Ltd.; part of aggregate ~$19.3M purchase price for four vet lab businesses; employee counts not disclosed
1996-12-31	acquisition_addition	completed		1996-05-15	1996-05-15	United States (Colorado, Illinois, Oklahoma)	Veterinary laboratory services		business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Acquisition of all capital stock of Veterinary Services, Inc.; part of aggregate ~$19.3M purchase price for four vet lab businesses; employee counts not disclosed
1996-12-31	acquisition_addition	completed		1996-07-12	1996-07-12	United States (California, Oregon, Nevada)	Veterinary laboratory services		business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Acquisition of assets of Consolidated Veterinary Diagnostics, Inc.; part of aggregate ~$19.3M purchase price for four vet lab businesses; employee counts not disclosed
1996-12-31	acquisition_addition	completed		1996-07-18	1996-07-18	Sweden	Animal health diagnostics		business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Acquisition of all capital stock for $400,000 plus assumed liabilities; employee counts not disclosed
1996-12-31	acquisition_addition	completed		1996-08-29	1996-08-29	United States (California)	Food, agricultural and environmental testing		business_combinations_footnote f5-10k / MiMo-V2.6-Flash-fp8-HTML	Merger accounted for as pooling-of-interests; ~$20M in stock value issued; employee counts not disclosed
1996-09-30	acquisition_addition	completed		1996-03-29		United States (Texas)	Veterinary reference laboratories		business_combinations_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Acquisition of all capital stock of VetLab, Inc., operating two veterinary reference laboratories in Texas; no employee count disclosed. Occurred in Q1 1996, before the current reporting period.
1996-09-30	acquisition_addition	completed		1996-04-02		United Kingdom	Veterinary reference laboratories		business_combinations_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Acquisition of substantially all assets of Grange Laboratories Ltd., now a division of IDEXX Laboratories, Limited; no employee count disclosed. Occurred in Q2 1996, before the current reporting period.
1996-09-30	acquisition_addition	completed		1996-05-15		United States (Colorado, Illinois, Oklahoma)	Veterinary reference laboratories		business_combinations_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Acquisition of all capital stock of Veterinary Services, Inc.; no employee count disclosed. Occurred in Q2 1996, before the current reporting period.
1996-09-30	acquisition_addition	completed		1996-07-12		United States (Northern California, Oregon, Nevada)	Veterinary reference laboratories		business_combinations_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Acquisition of substantially all assets of Consolidated Veterinary Diagnostics, Inc.; no employee count disclosed.
1996-09-30	acquisition_addition	completed		1996-07-18		Sweden (Uppsala)	Manufacturing and distribution of livestock diagnostic test kits		business_combinations_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Acquisition of all capital stock of Ubitech Aktiebolag; no employee count disclosed.
1996-09-30	acquisition_addition	completed		1996-08-29		United States (Sunnyvale, California)	Detection tests for food, agricultural and environmental industries		business_combinations_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Merger acquisition of Idetek, Inc.; accounted for as pooling-of-interests; 436,804 shares issued plus options for 110,191 shares; no employee count disclosed.
1996-09-30	acquisition_addition	completed		1996-03-29		Texas	Veterinary reference laboratories		business_combinations_footnote f5-10q / Qwen3.6-27B-Q8_0	Acquired VetLab, Inc. Headcount not disclosed.
1996-09-30	acquisition_addition	completed		1996-04-02		United Kingdom	Veterinary reference laboratories		business_combinations_footnote f5-10q / Qwen3.6-27B-Q8_0	Acquired Grange Laboratories Ltd. Headcount not disclosed.
1996-09-30	acquisition_addition	completed		1996-05-15		Colorado, Illinois, Oklahoma	Veterinary reference laboratories		business_combinations_footnote f5-10q / Qwen3.6-27B-Q8_0	Acquired Veterinary Services, Inc. Headcount not disclosed.
1996-09-30	acquisition_addition	completed		1996-07-12		Northern California, Oregon, Nevada	Veterinary reference laboratories		business_combinations_footnote f5-10q / Qwen3.6-27B-Q8_0	Acquired Consolidated Veterinary Diagnostics, Inc. Headcount not disclosed.
1996-09-30	acquisition_addition	completed		1996-07-18		Sweden	Diagnostic test kits		business_combinations_footnote f5-10q / Qwen3.6-27B-Q8_0	Acquired Ubitech Aktiebolag. Headcount not disclosed.
1996-09-30	acquisition_addition	completed		1996-08-29		California	Detection tests		business_combinations_footnote f5-10q / Qwen3.6-27B-Q8_0	Acquired Idetek, Inc. via merger. Headcount not disclosed.
1996-06-30	acquisition_addition	completed		1996-03-29	1996-03-29	United States (Texas)	Veterinary reference laboratories		business_combinations_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Acquired all capital stock of VetLab, Inc., operating two veterinary reference laboratories in Texas; part of three lab acquisitions totaling about $2.6 million. No employee count disclosed.
1996-06-30	acquisition_addition	completed		1996-04-02	1996-04-02	United Kingdom	Veterinary reference laboratories		business_combinations_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	UK subsidiary acquired substantially all assets of Grange Laboratories Ltd., three veterinary reference laboratories, now a division of IDEXX Laboratories, Limited; part of the $2.6 million aggregate. No employee count disclosed.
1996-06-30	acquisition_addition	completed		1996-05-15	1996-05-15	United States (Colorado, Illinois, Oklahoma)	Veterinary reference laboratories		business_combinations_footnote f5-10q / MiMo-V2.6-Flash-fp8-HTML	Acquired all capital stock of Veterinary Services, Inc., operating veterinary reference laboratories in three states; part of the $2.6 million aggregate. No employee count disclosed.
1996-06-30	acquisition_addition	announced		1996-07-12	1996-07-12	United States (Northern California, Oregon, Nevada)	Veterinary reference laboratories	USD 17 (millions)	subsequent_events f5-10q / MiMo-V2.6-Flash-fp8-HTML	Post-quarter acquisition of substantially all assets of Consolidated Veterinary Diagnostics, Inc. for about $17 million in cash and notes, plus up to $3.0 million contingent on results through July 31, 1997; five-year non-competes entered. No employee count disclosed.
1996-06-30	acquisition_addition	announced		1996-07-18	1996-07-18	Sweden (Uppsala)	Livestock diagnostic kits manufacturing and distribution	USD 0 (millions)	subsequent_events f5-10q / MiMo-V2.6-Flash-fp8-HTML	Post-quarter acquisition of all capital stock of Ubitech Aktiebolag for about $400,000 in cash. No employee count disclosed.
1996-06-30	acquisition_addition	announced		1996-07-17		United States (Sunnyvale, California)	Food, agricultural and environmental diagnostic tests	USD 20 (millions)	subsequent_events f5-10q / MiMo-V2.6-Flash-fp8-HTML	Post-quarter definitive merger agreement to acquire Idetek, Inc. in IDEXX stock valued at about $20 million, subject to adjustments and Idetek shareholder approval; intended to be treated as a pooling-of-interests transaction. No employee count disclosed.